1
Clinical Trials associated with Gan Fu Le TabletRandomized, Double-Blind, Placebo-Controlled, Multicenter Expanding Phase III Clinical Trial to Evaluate the Safety and Efficacy of Injectable Tyroserleutide to Treat Hepatocellular Carcinoma (HCC) (After HCC Resection)
This is a randomized, double-blinded, placebo-controlled, multi-center Clinical Trial. Patients with no tumor lesions 21 days after resection of hepatocellular carcinoma will be randomized in a 1:1 ratio to 1 of the 2 treatment groups:6mg/d Tyroserleutide (injection), or placebo
100 Clinical Results associated with Gan Fu Le Tablet
100 Translational Medicine associated with Gan Fu Le Tablet
100 Patents (Medical) associated with Gan Fu Le Tablet
100 Deals associated with Gan Fu Le Tablet